Voltage-dependent L-type calcium channel subunit alpha-1F
Also known as: CACNA1F, CACNAF1
Function
Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, and by benzothiazepines. Activates at more negative voltages and does not undergo calcium-dependent inactivation (CDI), due to incoming calcium ions, during depolarization.
Classification
- Family (Pfam)
- PF08763 Ca_chan_IQ, PF16885 CAC1F_C, PF16905 GPHH, PF00520 Ion_trans
- InterPro
- CAC1F_C, GPHH_dom, Ion_trans_dom, VDCC_a1su_IQ, VDCC_alpha-1_subunit, VDCC_L_a1su, VDCCAlpha1, Volt_channel_dom_sf
- Functional cluster
- G Protein-Coupled Receptors
Gene Ontology · 11
- GO:0016020 membrane
- GO:0043204 perikaryon
- GO:0001750 photoreceptor outer segment
- GO:0005891 voltage-gated calcium channel complex
- GO:0008331 high voltage-gated calcium channel activity
- GO:0046872 metal ion binding
- GO:0005245 voltage-gated calcium channel activity
- GO:0098703 calcium ion import across plasma membrane
- GO:0050908 detection of light stimulus involved in visual perception
- GO:1901386 negative regulation of voltage-gated calcium channel activity
- GO:0007601 visual perception
Disease associations
- congenital stationary night blindness 2A MONDO:0010241
- X-linked cone-rod dystrophy 3 MONDO:0010335
- Aland island eye disease MONDO:0010371
Drugs targeting this protein · 36
- PREGABALIN modulator
- MANIDIPINE 6300 blocker
- NICARDIPINE HYDROCHLORIDE blocker
- BEPRIDIL HYDROCHLORIDE blocker
- AMLODIPINE BESYLATE blocker
- DILTIAZEM MALATE blocker
- AMLODIPINE MALEATE blocker
- DRONEDARONE HYDROCHLORIDE blocker
- CLEVIDIPINE blocker
- AZELNIDIPINE blocker
- VERAPAMIL HYDROCHLORIDE blocker
- NIMODIPINE blocker
- FELODIPINE blocker
- GABAPENTIN ENACARBIL modulator
- ISRADIPINE blocker
- DILTIAZEM HYDROCHLORIDE blocker
- NISOLDIPINE blocker
- NIFEDIPINE blocker
- BENIDIPINE blocker
- BARNIDIPINE blocker
- IMAGABALIN modulator
- LERCANIDIPINE HYDROCHLORIDE blocker
- ELPETRIGINE blocker
- AZD1305 blocker
- SULOCTIDIL blocker
- CINNARIZINE blocker
- CILNIDIPINE blocker
- AMLODIPINE BENZOATE blocker
- LEVAMLODIPINE MALEATE blocker
- LACIDIPINE blocker
- PHLOROGLUCINOL blocker
- NITRENDIPINE blocker
- NILVADIPINE blocker
- TERODILINE HYDROCHLORIDE blocker
- ATAGABALIN modulator
- GABAPENTIN modulator
Related proteins · sequence + function similarity
- Voltage-dependent L-type calcium channel subunit alpha-1F 0.99
- Voltage-dependent T-type calcium channel subunit alpha-1G 0.89
- Voltage-dependent T-type calcium channel subunit alpha-1I 0.89
- Voltage-dependent L-type calcium channel subunit alpha-1S 0.88
- Voltage-dependent T-type calcium channel subunit alpha-1I 0.88
- Voltage-dependent T-type calcium channel subunit alpha-1H 0.88
- Voltage-dependent T-type calcium channel subunit alpha-1G 0.88
- Voltage-dependent T-type calcium channel subunit alpha-1H 0.88
- Dihydropyridine-sensitive L-type skeletal muscle calcium channel subunit alpha-1 0.87
- Voltage-dependent T-type calcium channel subunit alpha-1H 0.87
- Voltage-dependent L-type calcium channel subunit alpha-1S 0.87
- Voltage-dependent L-type calcium channel subunit alpha-1S 0.87
Co-cited proteins · studied together in the literature
- Voltage-dependent L-type calcium channel subunit alpha-1F 1 shared papers
- Calcium-binding protein 4 1 shared papers
- Proteolipid protein 2 1 shared papers
- Prickle planar cell polarity protein 3 1 shared papers
- Synaptophysin 1 shared papers
Literature · 15 cited papers
- Characterization of C-terminal Splice Variants of Cav1.4 Ca2+ Channels in Human Retina. J. Biol. Chem. · 2016
- A novel p.Gly603Arg mutation in CACNA1F causes Aland island eye disease and incomplete congenital stationary night blindness phenotypes in a family. Mol. Vis. · 2011
- Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol. Pharmacol. · 2009
- A novel CACNA1F gene mutation causes Aland Island eye disease. Invest. Ophthalmol. Vis. Sci. · 2007
- Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am. J. Hum. Genet. · 2006
- X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene. J. Med. Genet. · 2006
- A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proc. Natl. Acad. Sci. U.S.A. · 2005
- The DNA sequence of the human X chromosome. Nature · 2005
- Infantile and childhood retinal blindness: a molecular perspective (The Franceschetti Lecture). Ophthalmic Genet. · 2002
- Thirty distinct CACNA1F mutations in 33 families with incomplete type of XLCSNB and Cacna1f expression profiling in mouse retina. Eur. J. Hum. Genet. · 2002
- A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants. Hum. Genet. · 2001
- Isolation and characterization of a calcium channel gene, cacna1f, the murine orthologue of the gene for incomplete X-linked congenital stationary night blindness. Genomics · 2000
- … and 3 more in the literature graph
A document in the lmmol reference corpus — open public data (UniProt, GO, PDB, the literature graph) rendered as a single cross-linked page. Hover any link to preview its target.